Compatibility of calcipotriene with other topical medications.
Patel
B
B
Bristol-Myers Squibb Pharmaceutical Research Institute, Buffalo, New York, USA.
Siskin
S
S
Krazmien
R
R
Lebwohl
M
M
D000287:Administration, Topical; D002117:Calcitriol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004338:Drug Combinations; D004355:Drug Stability; D006801:Humans; D009824:Ointments; D011565:Psoriasis / Q000188:drug therapy*
D003879:Dermatologic Agents; D004338:Drug Combinations; D009824:Ointments; C055085:calcipotriene; D002117:Calcitriol